Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
AbbVie Inc | 319.3B | 67.0x | -6.05% |
Amgen Inc | 153.4B | 22.8x | -0.22% |
AstraZeneca PLC | 210.5B | 35.5x | +17.52% |
Bristol-Myers Squibb Co | 107.7B | 14.1x | +4.90% |
Eli Lilly and Co | 739.9B | 134.1x | +12.51% |
Gilead Sciences Inc | 91.0B | 16.3x | +1.53% |
Harmony Biosciences Holdings Inc | 1.9B | 15.7x | --- |
Jazz Pharmaceuticals PLC | 7.5B | 19.7x | -3.53% |
Johnson & Johnson | 380.6B | 29.9x | -1.47% |
Merck & Co Inc | 333.7B | 1,011.8x | -43.23% |
Novartis AG | 210.0B | 23.5x | -5.59% |
Pacira Biosciences Inc | 1.4B | 43.0x | --- |
Pfizer Inc | 157.3B | 77.2x | -7.10% |
Royalty Pharma PLC | 18.2B | 12.0x | +1.83% |
Sanofi SA | 125.7B | 20.9x | +4.55% |
Viatris Inc | 14.0B | 282.1x | -41.37% |
Amphastar Pharmaceuticals Inc | 2.1B | 17.0x | --- |
ANI Pharmaceuticals Inc | 1.5B | 84.2x | -8.16% |
Bavarian Nordic A/S | 1.8B | 7.9x | --- |
Bon Natural Life Ltd | 5.6M | 0.8x | +78.05% |
Collegium Pharmaceutical Inc | 1.3B | 44.0x | --- |
Corcept Therapeutics Inc | 2.6B | 26.4x | +9.80% |
CV Sciences Inc | 6.0M | 3.8x | --- |
Dr Reddy's Laboratories Ltd | 12.1B | 19.5x | +32.29% |
Earth Science Tech Inc | 22.0M | 69.8x | --- |
Endexx Corp | 11.5M | 1.8x | --- |
GSK plc | 89.2B | 14.1x | +6.39% |
HALEON PLC | 38.0B | 29.8x | --- |
HUTCHMED (China) Ltd | 3.0B | 29.2x | --- |
Innoviva Inc | 966.7M | 6.8x | -9.89% |
Invitro International | 1.1M | 127.1x | -17.03% |
LifeVantage Corp | 79.9M | 26.1x | -16.83% |
Ligand Pharmaceuticals Inc | 1.3B | 25.1x | -12.71% |
Novo Nordisk A/S | 439.6B | 47.5x | +18.50% |
Organon & Co | 4.7B | 4.7x | -14.04% |
Procaps Group SA | 313.7M | 5.6x | --- |
Roche Holding AG | 204.6B | 16.1x | +3.28% |
Roivant Sciences Ltd | 8.7B | 2.1x | --- |
SCYNEXIS Inc | 53.0M | 1.1x | --- |
SIGA Technologies Inc | 604.3M | 9.1x | -28.78% |
Takeda Pharmaceutical Co Ltd | 45.8B | 37.3x | -3.20% |
Taro Pharmaceutical Industries Ltd | 1.6B | 34.8x | -33.66% |
United-Guardian Inc | 35.6M | 13.6x | -9.92% |
Zhong Yuan Bio-Technology Holdings Ltd | 88.4M | 392.2x | --- |
Acasti Pharma Inc | 32.0M | -0.7x | --- |
AgriFORCE Growing Systems Ltd | 967.1K | 0.0x | --- |
Akanda Corp | 2.0M | 0.0x | --- |
Aptorum Group Ltd | 45.1M | -2.6x | --- |
Aquestive Therapeutics Inc | 349.3M | -29.6x | --- |
Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.
Company | Dividend Yield |
---|---|
Sanofi SA (ADR) | 7.95% |
Takeda Pharmaceutical Co Ltd (ADR) | 6.76% |
Organon & Co | 6.07% |
Pfizer Inc | 6.05% |
United-Guardian, Inc. | 4.51% |